All these results support that ALT levels are related to some metabolically abnormal systemic condition, and it may have contributed to the negative effect of high ALT NAFLD on BMD in the secondary analysis of this study. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.